Despite an inflationary environment and recession concerns that dampened consumer spending, legal cannabis sales in the U.S. will reach $27 billion by the end of 2022, a jump of 7% over 2021 sales.

The company’s Retail Sales Tracking solution is based on sales data from its cannabis retail partners across the U.S.

The company’s cannabis data library includes cannabinoid and terpene strain profiles from the Leafly-Certified Labs Program, subjective strain effects from consumer reviews, and cannabis popularity metrics.

Emerging markets are expected to be a major driver of sales through 2026, as the number of non-legal states rapidly dwindles.

Eaze’s report shows significant consumer interest in cannabis brands produced by social equity licensees.

The market research firm said data surrounding the Missouri legal medical market category, brands, product sales, and trends will be available.

Sales for all regulated cannabis products are expected to top $27.1 billion in 2021, up around 25 percent from 2020, according to Kelly Nielsen, vice president of insights and analytics, BDSA.

Rebecca Maestas, brand development manager for LivWell Enlightened Health, presented her expertise in understanding customer needs — for both the business-to-business and business-to-consumer channels — during Cannabis Products Exchange, hosted virtually April 27-28.